Legend Short Ratio

LEGN Stock

USD 48.22 0.22 0.46%

Legend BiotechCorp fundamentals help investors to digest information that contributes to Legend BiotechCorp's financial success or failures. It also enables traders to predict the movement of Legend Stock. The fundamental analysis module provides a way to measure Legend BiotechCorp's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Legend BiotechCorp stock.

This module does not cover all equities due to inconsistencies in global equity categorizations. Continue to Equity Screeners to view more equity screening tools.

Current Assets Total Assets

Legend Short Ratio Analysis

Legend BiotechCorp's Short Ratio is typically used by traders and speculators to identify trends in current market sentiment for a particular equity instrument. In its simple terms this ratio shows how many days it will take all current short sellers to cover their positions if the price of a stock begins to rise.

	2020	2021	2022	2023 (projected)
Interest Expense	4.21 M	900 K	1.03 M	1.33 M
Gross Profit	75 M	68.83 M	79.15 M	78.27 M

Interest Expense Gross Profit

Short Ratio

Short Interest

Average Trading Volume

More About Short Ratio | All Equity Analysis

Current Legend BiotechCorp Short Ratio

9.52 X

Most of Legend BiotechCorp's fundamental indicators, such as Short Ratio, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Legend BiotechCorp is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.

Legend Short Ratio Driver Correlations

Understanding the fundamental principles of building solid financial models for Legend BiotechCorp is extremely important. It helps to project a fair market value of Ford stock properly, considering its historical fundamentals such as Short Ratio. Since Legend BiotechCorp's main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of Legend BiotechCorp's historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of Legend BiotechCorp's interrelated accounts and indicators.

	Total Assets	Current Assets	Cash and Equivalents	Total Debt	Debt Current	Deferred Revenue	Shareholders Equity	Investments Current	Total Liabilities	Current Liabilities	Tax Assets	Tax Liabilities
Total Assets		1.0	0.97	0.94	0.64	0.86	0.98	0.91	0.97	0.97	-0.76	-0.76
Current Assets	1.0		0.97	0.94	0.64	0.86	0.98	0.91	0.97	0.97	-0.75	-0.75
Cash and Equivalents	0.97	0.97		0.97	0.69	0.92	0.99	0.93	0.97	0.95	-0.82	-0.82
Total Debt	0.94	0.94	0.97		0.55	0.89	0.93	0.99	0.98	0.97	-0.84	-0.84
Debt Current	0.64	0.64	0.69	0.55		0.78	0.67	0.41	0.56	0.48	-0.48	-0.48
Deferred Revenue	0.86	0.86	0.92	0.89	0.78		0.88	0.83	0.89	0.83	-0.91	-0.91
Shareholders Equity	0.98	0.98	0.99	0.93	0.67	0.88		0.91	0.94	0.94	-0.78	-0.78
Investments Current	0.91	0.91	0.93	0.99	0.41	0.83	0.91		0.97	0.97	-0.83	-0.83
Total Liabilities	0.97	0.97	0.97	0.98	0.56	0.89	0.94	0.97		0.99	-0.84	-0.84
Current Liabilities	0.97	0.97	0.95	0.97	0.48	0.83	0.94	0.97	0.99		-0.8	-0.8
Tax Assets	-0.76	-0.75	-0.82	-0.84	-0.48	-0.91	-0.78	-0.83	-0.84	-0.8		1.0
Tax Liabilities	-0.76	-0.75	-0.82	-0.84	-0.48	-0.91	-0.78	-0.83	-0.84	-0.8	1.0

Click cells to compare fundamentals

The higher the Short Ratio, the longer it would take to buy back the borrowed shares. In theory, the more short positions are currently outstanding, the faster it will be to cover shorted positions.

Competition

Predict Legend BiotechCorp

Legend Net Cash Flow from Operations

Net Cash Flow from Operations

(184.3 Million)

Legend BiotechCorp Net Cash Flow from Operations is very stable at the moment as compared to the past year. Legend BiotechCorp reported last year Net Cash Flow from Operations of (179.58 Million)

Based on the latest financial disclosure, Legend BiotechCorp has a Short Ratio of 9.52 times. This is 144.1% higher than that of the Healthcare sector and 28.48% higher than that of the Biotechnology industry. The short ratio for all United States stocks is 138.0% lower than that of the firm.

Legend Short Ratio Peer Comparison

Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Legend BiotechCorp's direct or indirect competition against its Short Ratio to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Legend BiotechCorp could also be used in its relative valuation, which is a method of valuing Legend BiotechCorp by comparing valuation metrics of similar companies.

Legend BiotechCorp is currently under evaluation in short ratio category among related companies.

Legend BiotechCorp Institutional Holders

Institutional Holdings refers to the ownership stake in Legend BiotechCorp that is held by large financial organizations, pension funds or endowments. Institutions may purchase large blocks of Legend BiotechCorp's outstanding shares and can exert considerable influence upon its management. Institutional holders may also work to push the share price higher once they own the stock. Extensive social media coverage, TV shows, articles in high-profile magazines, and presentations at investor conferences help move the stock higher, increasing Legend BiotechCorp's value.

	Last Transaction	Type	Shares	Value
Fmr Llc	2022-12-31	Common Shares	15.1 M	755.9 M
Hhlr Advisors Ltd	2022-12-31	Common Shares	5.1 M	256.4 M
Blackrock Inc	2022-12-31	Common Shares	3.9 M	193.6 M
Ra Capital Management Lp	2022-12-31	Common Shares	2.4 M	121.6 M
Capital World Investors	2022-12-31	Common Shares	2.4 M	119.3 M
Federated Hermes Inc	2022-12-31	Common Shares	2.3 M	116.8 M
Capital International Investors	2022-12-31	Common Shares	2.2 M	108.3 M
Janus Henderson Group Plc	2022-12-31	Common Shares	1.8 M	92.2 M
Wellington Management Group Llp	2022-12-31	Common Shares	1.8 M	90.5 M
Johnson Johnson	2022-12-31	Common Shares	1.6 M	81.3 M
Alliancebernstein Lp	2022-12-31	Common Shares	1.3 M	64.5 M

Legend Fundamentals

	Return On Equity	(0.97) %
	Return On Asset	(0.26) %
	Operating Margin	(3.29) %
	Current Valuation	8.02 B
	Shares Outstanding	167.4 M
	Shares Owned by Insiders	1.36 %
	Shares Owned by Institutions	38.67 %
	Number of Shares Shorted	5.11 M
	Price to Book	19.80 X
	Price to Sales	73.18 X
	Revenue	89.79 M
	Gross Profit	91.56 M
	EBITDA	(385.31 M)
	Net Income	(386.21 M)
	Cash and Equivalents	791.26 M
	Cash per Share	5.11 X
	Total Debt	120.46 M
	Debt to Equity	0.29 %
	Current Ratio	3.83 X
	Book Value Per Share	3.63 X
	Cash Flow from Operations	(198.47 M)
	Short Ratio	9.52 X
	Earnings Per Share	(3.14) X
	Target Price	70.89
	Number of Employees	1.07 K
	Beta	-0.0875
	Market Capitalization	7.85 B
	Total Asset	1.12 B
	Z Score	39.0
	Net Asset	1.12 B

About Legend BiotechCorp Fundamental Analysis

The Macroaxis Fundamental Analysis modules help investors analyze Legend BiotechCorp's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Legend BiotechCorp using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Legend BiotechCorp based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.

Please read more on our fundamental analysis page.

Legend Biotech Corporation, a clinical-stage biopharmaceutical company, through its subsidiaries, engages in the discovery and development of novel cell therapies for oncology and other indications in the United States, China, and internationally. Legend Biotech Corporation is a subsidiary of Genscript Biotech Corporation. Legend Biotech operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 1071 people.

Legend BiotechCorp Investors Sentiment

The influence of Legend BiotechCorp's investor sentiment on the probability of its price appreciation or decline could be a good factor in your decision-making process regarding taking a position in Legend. The overall investor sentiment generally increases the direction of a stock movement in a one-year investment horizon. However, the impact of investor sentiment on the entire stock markets does not have a solid backing from leading economists and market statisticians.

Investor biases related to Legend BiotechCorp's public news can be used to forecast risks associated with investment in Legend. The trend in average sentiment can be used to explain how an investor holding Legend can time the market purely based on public headlines and social activities around Legend BiotechCorp. Please note that most equiteis that are difficult to arbitrage are affected by market sentiment the most.

Legend BiotechCorp's market sentiment shows the aggregated news analyzed to detect positive and negative mentions from the text and comments. The data is normalized to provide daily scores for Legend BiotechCorp's and other traded tickers. The bigger the bubble, the more accurate is the estimated score. Higher bars for a given day show more participation in the average Legend BiotechCorp's news discussions. The higher the estimated score, the more favorable is the investor's outlook on Legend BiotechCorp.

Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Legend BiotechCorp in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Legend BiotechCorp's short interest history, or implied volatility extrapolated from Legend BiotechCorp options trading.

Becoming a Better Investor with Macroaxis

Macroaxis puts the power of mathematics on your side. We analyze your portfolios and positions such as Legend BiotechCorp using complex mathematical models and algorithms, but make them easy to understand. There is no real person involved in your portfolio analysis. We perform a number of calculations to compute absolute and relative portfolio volatility, correlation between your assets, value at risk, expected return as well as over 100 different fundamental and technical indicators.

Build Optimal Portfolios

Align your risk with return expectations

By capturing your risk tolerance and investment horizon Macroaxis technology of instant portfolio optimization will compute exactly how much risk is acceptable for your desired return expectations

Fix portfolios for free

Check out Legend BiotechCorp Piotroski F Score and Legend BiotechCorp Altman Z Score analysis. To learn how to invest in Legend Stock please use our How to Invest in Legend BiotechCorp guide. Note that the Legend BiotechCorp information on this page should be used as a complementary analysis to other Legend BiotechCorp's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try Correlation Analysis module to reduce portfolio risk simply by holding instruments which are not perfectly correlated.

Complementary Tools for Legend Stock analysis

When running Legend BiotechCorp price analysis, check to measure Legend BiotechCorp's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Legend BiotechCorp is operating at the current time. Most of Legend BiotechCorp's value examination focuses on studying past and present price action to predict the probability of Legend BiotechCorp's future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move Legend BiotechCorp's price. Additionally, you may evaluate how the addition of Legend BiotechCorp to your portfolios can decrease your overall portfolio volatility.

	Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio
	Bollinger Bands Use Bollinger Bands indicator to analyze target price for a given investing horizon
	Risk-Return Analysis View associations between returns expected from investment and the risk you assume
	Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes
	Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance
	Share Portfolio Track or share privately all of your investments from the convenience of any device

Is Legend BiotechCorp's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Legend BiotechCorp. If investors know Legend will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Legend BiotechCorp listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.

Earnings Share

(3.14)

Revenue Per Share

0.788

Quarterly Revenue Growth

(0.42)

Return On Assets

(0.26)

Return On Equity

(0.97)

The market value of Legend BiotechCorp is measured differently than its book value, which is the value of Legend that is recorded on the company's balance sheet. Investors also form their own opinion of Legend BiotechCorp's value that differs from its market value or its book value, called intrinsic value, which is Legend BiotechCorp's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Legend BiotechCorp's market value can be influenced by many factors that don't directly affect Legend BiotechCorp's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.

Please note, there is a significant difference between Legend BiotechCorp's value and its price as these two are different measures arrived at by different means. Investors typically determine Legend BiotechCorp value by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Legend BiotechCorp's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2023 Macroaxis LLC

Legend Short Ratio

Legend Short Ratio Analysis

Current Legend BiotechCorp Short Ratio

Legend Short Ratio Driver Correlations

Legend Net Cash Flow from Operations

Net Cash Flow from Operations

(184.3 Million)

Legend Short Ratio Peer Comparison

Legend BiotechCorp Institutional Holders

Legend Fundamentals

About Legend BiotechCorp Fundamental Analysis

Legend BiotechCorp Investors Sentiment

Becoming a Better Investor with Macroaxis

Build Optimal Portfolios

Align your risk with return expectations

Complementary Tools for Legend Stock analysis

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY